Stay updated with breaking news from Precision Pathology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers at the University of Pennsylvania have developed a new artificial intelligence (AI) tool called iStar (Inferring Super-Resolution Tissue Architecture) that has the potential to revolutionize cancer diagnosis and treatment
BioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, today announced the appointment of Jamie...
BioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer and lung disease, today announced that David Elzi,...
/PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, and CorePlus Servicios Clínicos y Patológicos, LLC (CorePlus), a...
SAN ANTONIO--(BUSINESS WIRE)--#BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and six months ended June 30, 2023, and provided a...